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The vaccination rates of Japanese people travelling abroad are still relatively low compared to travelers
from Europe and the U.S. The following 3 causes are considered to contribute to the low vaccination rates
among Japanese. First point is the lack of attention to the prevention of diseases during overseas travel in
Japanese people. Second point is the limited number of healthcare facilities where Japanese overseas
travelers can receive vaccinations. Third, many vaccines administered to travelers are still unapproved in
Japan. However, there appear to be recent developments in each matter. With these social changes, the
vaccination rate should be improved by disseminating recognition of the importance of the travel
medicine in Japan. This report summarizes the present situation of vaccination of Japanese overseas
travelers and discusses the challenges to improving vaccination rates.
© 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases.
Published by Elsevier Ltd. All rights reserved.1. Introduction
An increasing number of Japanese people are travelling abroad
every year. According to the Statistical Survey on Legal Migrants by
Ministry of Justice, more than 18 million Japanese people traveled
abroad in 2012. Many of them visited developing countries
including some in Asia. Because the risk of acquiring infectious
diseases is higher in such countries, vaccinations are recommended
before leaving Japan. However, the vaccination rates of Japanese
people travelling abroad are still relatively low because of various
reasons. This report summarizes the present situation of vaccina-
tion of Japanese overseas travelers and discusses the challenges to
improving vaccination rates.
2. Vaccines for overseas travelers
Many infectious diseases with the risk for people traveling
overseas can be prevented by vaccination. Such vaccines for over-
seas travelers are called travelers' vaccines. These vaccines are
administered preferentially for diseases that carry a high incidencer, Tokyo Medical University
160-0023, Japan. Tel.: þ81 03
mada).
d The Japanese Association for Infectiand severity of illness [1]. Candidate vaccines are selected precisely
by considering the style of traveler, including their age, area to be
visited, intended duration of visit, and intended lifestyle at the site
to be visited (Table 1). Information on the types of infectious dis-
eases endemic to the area the traveler intends to visit is critical in
selecting vaccines and is obtainable from the WHOwebsite (http://
www.who.int/ith/en/) and other sources. Typically, vaccines for
hepatitis A, typhoid fever, and yellow fever are administered for
short-term (less than 1 month) visits to developing countries. In
addition, vaccinations for tetanus, hepatitis B, rabies, Japanese en-
cephalitis, polio, and meningococcal meningitis are recommended
for long-term travelers.
In many cases, overseas travelers are short on time before their
departure and have to ﬁnish getting the required immunizations
under time pressure. Therefore, administration of all the vaccines
needs to be ﬁnished within a short period of time. Many inactivated
vaccines must be given 3 times to complete immunization sched-
ules (Table 2). For travelers who are short on time, however, a
minimum of 2 doses (usually 1 month apart) should be given to
exert a protective effect at the expected level. For travelers who
have insufﬁcient time for a normal administration schedule,
different vaccines can be administered simultaneously. Simulta-
neous administration of more than two different vaccines does not
reduce the effectiveness of each vaccine and does not synergisti-
cally increase the severity of adverse events.ous Diseases. Published by Elsevier Ltd. All rights reserved.
Table 1
Vaccines recommended for Japanese adults traveling abroad.B: Recommended;△: Recommended depending on circumstances.
Vaccine Visit durationa Areas for which vaccination
is recommended
Travelers for whom vaccination is strongly recommended
Short Long
Hepatitis A B B Developing countries Visitors to areas with poor sanitation
Typhoid fever
(not approved in Japan)
△ B Developing countries Visitors to South Asia
Yellow fever △ B Tropical Africa
South America
Visitors to countries that require a certiﬁcate of vaccination for entry
Tetanus △ B Entire world Visitors who are at risk of suffering traumatic injury
Hepatitis B B Developing countries Visitors who will be working as medical practitioners
Rabies △ B Developing countries Visitors to areas where post-exposure prophylaxis is not readily available
Japanese encephalitis △ China
South-East and South Asia
Visitors to rural areas
Polio △ South Asia
Africa
Visitors who were born between 1975 and 1977 in Japan
(Less effective vaccines were used in children during this period.)
Meningococcal meningitis △ West Africa Visitors intending to stay during the dry season
a Short: Less than 1 month.
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In the late 1990s, a survey of vaccination status among foreign
travelers was conducted by a travel clinic at Kathmandu, Nepal [2].
The results show that only 5% of Japanese travelers were admin-
istered either hepatitis A or typhoid fever vaccine in contrast to 90%
of travelers from Europe and the U.S., who were vaccinated against
both.
Thus, this survey indicates overseas travelers from Europe and
the U.S. have a very high rate of vaccine administration. For
example, surveys conducted at the Munich Airport in Germany [3]
and the J. F. Kennedy Airport in New York [4] indicates 59%
(n¼ 5776) and 24% (n¼ 404), respectively, who departed for
developing countries were administered hepatitis A vaccine.
Moreover, a survey conducted at an airport in Australia indicates
31% and 26% of 340 overseas tourists received hepatitis A and
typhoid fever vaccine, respectively [5].
Besides the survey of Japanese travelers in Kathmandu, Hitani
et al. [6] investigated the vaccination status of 93 Japanese overseas
tourists who departed for African countries or other areas in
2001e2002. The results show a high vaccination rate (71.4%) for
yellow fever in contrast to a low rate for hepatitis A (1.8%). Between
2007 and 2008, Namikawa et al. [7] investigated 302 Japanese
tourists and found that less than 10% had received any kind of
vaccine. These studies collectively indicate a very low rate of
vaccination among Japanese travelers before overseas departure.
In contrast, our surveys of Japanese people who stayed in
developing countries for business show higher vaccination rates.Table 2
Number of immunizations in Japan.
Vaccine Number of
immunizations
Common immunization
Hepatitis A (inactivated vaccine) 3 Day 0, Day 14 to 28, Mon
Typhoid fever (polysaccharide vaccine) 1 Day 0
Yellow fever (live attenuated vaccine) 1 Day 0
Tetanus (toxoid) 3 Day 0, Day 28, Month 6 t
Hepatitis B (DNA vaccine) 3 Day 0, Day 28, Month 6 t
Rabies (inactivated vaccine) 3 Day 0, Day 28, Month 6 t
Japanese encephalitis
(inactivated vaccine)
3 Day 0, Day 7 to 28, Mont
Polio (inactivated vaccine) 4 Day 0, Day 28, Month 2,
Meningococcal meningitis
(conjugate vaccine)
1 Day 0Our studies indicate pre-departure administration rates with some
kinds of vaccines tended to increase annually among Japanese
travelers of age 16 years or more: 45.6%, 49.9%, and 55.8% in 1998,
2002, and 2005, respectively (Fig.1) [8,9]. Japanese companies have
recently placed stronger emphasis on the health management of
employees residing abroad. Such efforts are considered to be the
reason for the increasing administration rate of vaccines.
4. Reasons for the low vaccination rate among Japanese
overseas travelers
The following 3 causes are considered to contribute to the low
vaccination rates among Japanese overseas travelers.
4.1. Poor disease preventive attention during overseas travel
The lack of attention to the prevention of diseases during
overseas travel is one reason for the low vaccination rate among
Japanese people. According to surveys conducted at airports in
Europe and the U.S. from 2002 to 2003, almost half of overseas
travelers received health advice from healthcare professionals
before departure [4,10]. In contrast, in Japan, similar surveys con-
ducted from 2007 to 2008 show that only 2% of overseas travelers
received such health advice before departure [7]. This low rate may
be reﬂected by the lack of attention among Japanese people to-
wards the prevention of diseases that may arise during overseas
travel. This attitude may result in the low vaccination rate before
departure.schedule Effective period Special instructions
th 6 to 12 5 to 10 years Foreign-made vaccines are given twice.
3 years Live attenuated vaccines are given 3 or 4 times.
10 years
o 12 10 years Administer once to those who have previously
received basic immunization.
o 12 10 years
o 12 2 to 5 years Foreign-made vaccines are given on days 0, 7,
and 21 to 28.
h 6 to 12 4 years Adults are vaccinated once or twice.
Month 12 10 years Adults are vaccinated once or twice.
3 to 5 years Polysaccharide vaccine is also given once.
Fig. 1. Vaccination rates in Japanese people dispatched to developing countries. From the surveys in “Visiting health consultation” by Japan Labour Health and Welfare Or-
ganization [8,9].
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There are only a handful of healthcare facilities where Japanese
overseas travelers can receive vaccinations. The numbers and lo-
cations of travel clinics are listed by country on the website of the
International Society of Travel Medicine (http://www.istm.org/).
Travel clinics are specialized healthcare facilities for overseas
travelers that provide necessary medical services such as vaccina-
tions. According to the website, there are 49 travel clinics in New
York State alone. In contrast, as of December 2014, there are only 33
travel clinics throughout Japan. Even though the number of travel
clinics listed on this website may not be accurate, it does reﬂect the
relatively few travel clinics in Japan.
Furthermore, there is a major difference between Japan and
Europe or the U.S. with regard to how front-line physicians are
involved in the medical care of overseas travelers. A survey of
family physicians conducted in the U.K. in 1998 revealed that more
than 80% were involved in practice for overseas travelers, including
the inoculation of vaccines for 10 or more travelers every month
[11]. However, in Japan, our survey of physicians certiﬁed by the
Japanese Society of Internal Medicine in 2005 revealed that less
than 10% provided medical care for 5 or more overseas travelers
every month [12]. These ﬁndings indicate that the low vaccination
rates among Japanese overseas travelers may at least in part be due
to the relative few healthcare facilities that provide vaccinations for
overseas travelers.
4.3. Problems associated with unapproved vaccines
Finally, many vaccines administered to travelers are still un-
approved in Japan. Cholera, tick-borne encephalitis, and typhoid
fever vaccines are unapproved in Japan even though they are
recommended for overseas travelers by International Travel &
Health, a periodical of the World Health Organization [13].
Furthermore, although hepatitis A and rabies vaccines, which are
also recommended for overseas travelers by the World Health
Organization, are approved in Japan, they are not supplied in
sufﬁcient quantities for routine use and are therefore sometimes
difﬁcult to obtain; therefore, in many Japanese travel clinics,
physicians import these vaccines privately for the vaccination of
overseas travelers (Fig. 2) [14]. However, foreign vaccine manu-
facturers tend to hesitate to apply for approval of new vaccines in
Japan because of the very strict Japanese vaccine approval
system.5. Recent developments
The issues discussed above are considered to contribute to the
low vaccination rates among Japanese overseas travelers. However,
there appear to be recent developments in each matter.
First, Japanese companies and the travel industry are making
large changes. Although Japanese people sent abroad for business
show relatively higher levels of vaccination rates as mentioned
above, recent trends indicate more companies recommend vacci-
nations for the safety of employees working abroad before they
leave Japan. In addition to this, as a result of the steep increase in
the number of overseas tourists, the Japanese travel industry has
become aware of the need to travelers' health issues. Furthermore,
after the 2005 amendment of the Travel Agency Act of Japan, travel
companies are obligated to provide health information to package
tour travelers. As a result of these trends, many Japanese people
have become aware of health issues when staying abroad as well as
the necessity of vaccinations before departure.
There have also been changes in organizations and professionals
that provide medical care. For example, the Japanese Society of
Travel and Health established a certiﬁcation system for medical
staff (physician, dentist, nurse and pharmacist) in 2007 to foster
medical experts in travel medicine; accordingly, more than 100
healthcare workers were certiﬁed members as of 2014. In 2012, the
society expanded its activities to support the establishment of
travel clinics. Such society-based activities and other efforts have
promoted establishment of travel clinics throughout Japan. As of
December 2014, a total of 82 facilities were listed in the clinic list of
the website operated by the Japanese Society of Travel and Health
(Fig. 3).
In 2005, the Ministry of Health, Labour, and Welfare of Japan
started a research project entitled “Studies on Vaccination for
Japanese Overseas Travelers,” which spurred major breakthroughs
for problems associated with unapproved vaccines. This research
project engaged in a variety of educational activities to increase the
vaccination rate of Japanese overseas travelers as well as clinical
studies of unapproved vaccines. These activities encouraged vac-
cine manufacturers to apply for approval of new traveler's vaccines
in Japan. As a result, the meningococcal meningitis vaccine will be
approved in Japan in 2014. Furthermore, the Ministry of Health,
Labour, and Welfare started discussing improvements to the vac-
cine approval system.
Thus, these social changes in Japan are resulting in gradual
improvement of the vaccination rates of overseas travelers.
Fig. 2. Present state of the use of unapproved vaccines in Japanese travel clinic. The state of the use of unapproved vaccines was investigated in 2013 by a questionnaire to travel
clinics listed on the website of the Japanese Society of Travel and Health. Answers were obtained from 25 clinics [14].
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Several challenges to the widespread adoption of traveler's
vaccines in Japan remain. First, guidelines indicating proper usage
of traveler's vaccines should be prepared for healthcare pro-
fessionals. The Japanese Society of Travel and Health released the
“Vaccination Guidelines for Overseas Travelers” in 2010 and is now
planning an updated version. New travel clinics have been estab-
lished every year. However, because there are inequalities in the
medical services among clinics, the quality of medical services
provided must be evaluated.
Education about disease preventive attention during travel
should be continued for citizens. As the vaccination rates for
overseas travelers are still low, further efforts should be encouraged
to improve the vaccination rate in conjunction with the travel in-
dustry. Furthermore, this education is necessary for international
students and emigrants including people who stay abroad for a
long period after retirement.
Furthermore, all vaccines have a variety of problems. In partic-
ular, immediate actions should be taken for problems associated
with the yellow fever vaccine. At present, the yellow fever vaccine
can be administered only at Quarantine Stations and their associ-
ated facilities. However, more equipped facilities should beFig. 3. Locations of travel clinics listed on the website of the Japanese Society of Travel
and Health (http://www.tramedjsth.jp/).established in the future. For other vaccines that have been already
approved in Japan, including hepatitis A and rabies vaccines,
manufacturers should be encouraged to maintain stable and sufﬁ-
cient supplies.7. Conclusion
Travel medicine, an academic discipline that deals with the
healthcare issues of overseas travelers, has been established for a
long time in Europe and the U.S. In contrast, in Japan, although the
importance of travel medicine has been increasing since the 2000s,
its visibility remains inadequate [15]. The vaccination rate of trav-
elers abroad should be improved by disseminating recognition of
the importance of the travel medicine in Japan.Conﬂicts of interest
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